REFERENCES
1. Goldman A,
Kulkarni A, Kohandel M, Pandey P, Rao P, Natarajan SK, et al. Rationally
Designed 2-in-1 Nanoparticles Can Overcome Adaptive Resistance in Cancer. ACS
Nano [Internet]. 2016 Jun 28 [cited 2024 Dec 11];10(6):5823–34. Available from:
https://pubmed.ncbi.nlm.nih.gov/27257911/
2. Han S, Chi Y,
Yang Z, Ma J, Wang L. Tumor Microenvironment Regulation and Cancer Targeting
Therapy Based on Nanoparticles. J Funct Biomater. 2023 Feb 28;14(3):136.
3. Adityan S,
Tran M, Bhavsar C, Wu SY. Nano-therapeutics for modulating the tumour
microenvironment: Design, development, and clinical translation. J Control
Release [Internet]. 2020;327(April):512–32. Available from:
https://doi.org/10.1016/j.jconrel.2020.08.016
4. Zheng R, Zhang
S, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in
China, 2016. J Natl Cancer Cent. 2022 Mar 1;2(1):1–9.
5. Al-Zoubi MS,
Al-Zoubi RM. Nanomedicine tactics in cancer treatment: Challenge and hope. Crit
Rev Oncol Hematol. 2022 Jun 1;174:103677.
6. Raju GSR,
Pavitra E, Varaprasad GL, Bandaru SS, Nagaraju GP, Farran B, et al.
Nanoparticles mediated tumor microenvironment modulation: current advances and
applications. J Nanobiotechnology [Internet]. 2022 Dec 1 [cited 2024 Dec
11];20(1):1–20. Available from:
https://jnanobiotechnology.biomedcentral.com/articles/10.1186/s12951-022-01476-9
7. Wu T, Dai Y.
Tumor microenvironment and therapeutic response. Cancer Lett [Internet]. 2017
Feb 28 [cited 2024 Dec 11];387:61–8. Available from:
https://pubmed.ncbi.nlm.nih.gov/26845449/
8. Feng Y, Tang
Q, Wang B, Yang Q, Zhang Y, Lei L, et al. Targeting the tumor microenvironment
with biomaterials for enhanced immunotherapeutic efficacy. J Nanobiotechnology
[Internet]. 2024 Dec 1 [cited 2024 Dec 11];22(1). Available from:
https://pubmed.ncbi.nlm.nih.gov/39605063/
9. Kim J, Hong J,
Lee J, Fakhraei Lahiji S, Kim YH. Recent advances in tumor
microenvironment-targeted nanomedicine delivery approaches to overcome
limitations of immune checkpoint blockade-based immunotherapy. J Control
Release. 2021 Apr 10;332:109–26.
10. Shen S, Gao Y,
Ouyang Z, Jia B, Shen M, Shi X. Photothermal-triggered dendrimer nanovaccines
boost systemic antitumor immunity. J Control Release. 2023 Mar 1;355:171–83.
11. Afzal M,
Ameeduzzafar, Alharbi KS, Alruwaili NK, Al-Abassi FA, Al-Malki AAL, et al.
Nanomedicine in treatment of breast cancer – A challenge to conventional
therapy. Semin Cancer Biol. 2021 Feb 1;69:279–92.
12. Bussard KM,
Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC. Tumor-associated stromal cells
as key contributors to the tumor microenvironment. Breast Cancer Res
[Internet]. 2016 Aug 11 [cited 2024 Dec 11];18(1). Available from:
https://pubmed.ncbi.nlm.nih.gov/27515302/
13. Jin C, Wang K,
Oppong-Gyebi A, Hu J. Application of nanotechnology in cancer diagnosis and
therapy - A mini-review. Int J Med Sci. 2020;17(18):2964–73.
14. Nguyen VH, Kim
HS, Ha JM, Hong Y, Choy HE, Min JJ. Genetically engineered Salmonella
typhimurium as an imageable therapeutic probe for cancer. Cancer Res
[Internet]. 2010 Jan 1 [cited 2024 Dec 11];70(1):18–23. Available from:
https://pubmed.ncbi.nlm.nih.gov/20028866/
15. Mosleh-Shirazi
S, Abbasi M, Moaddeli MR, Vaez A, Shafiee M, Kasaee SR, et al. Nanotechnology
Advances in the Detection and Treatment of Cancer: An Overview.
Nanotheranostics. 2022;6(4):400–23.
16. Dai Q,
Bertleff-Zieschang N, Braunger JA, Björnmalm M, Cortez-Jugo C, Caruso F.
Particle Targeting in Complex Biological Media. Adv Healthc Mater. 2018 Jan
10;7(1).
17. Navigating the
Future: Advancements in Monoclonal Antibody Nanoparticle Therapy for Cancer. J
Drug Deliv Sci Technol. 2024 Dec 6;106495.
18. Ray P. Curing
Cancer with Nanotherapy Continues to be an Elusive Goal. J Immunol Sci.
2021;5(2):36–9.
19. Zeng L, Gowda
BHJ, Ahmed MG, Abourehab MAS, Chen ZS, Zhang C, et al. Advancements in
nanoparticle-based treatment approaches for skin cancer therapy. Mol Cancer
[Internet]. 2023 Dec 1 [cited 2024 Dec 11];22(1). Available from:
https://pubmed.ncbi.nlm.nih.gov/36635761/
20. Chen L, Hong W,
Ren W, Xu T, Qian Z, He Z. Recent progress in targeted delivery vectors based
on biomimetic nanoparticles. Signal Transduct Target Ther [Internet]. 2021 Dec
1 [cited 2024 Dec 11];6(1). Available from:
https://pubmed.ncbi.nlm.nih.gov/34099630/
21. Siegel RL,
Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin
[Internet]. 2022 Jan [cited 2024 Dec 11];72(1):7–33. Available from:
https://pubmed.ncbi.nlm.nih.gov/35020204/
22. Kulkarni JA,
Witzigmann D, Chen S, Cullis PR, Van Der Meel R. Lipid Nanoparticle Technology
for Clinical Translation of siRNA Therapeutics. Acc Chem Res. 2019 Sep
17;52(9):2435–44.
23. Riley RS, June
CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat
Rev Drug Discov 2018 183 [Internet]. 2019 Jan 8 [cited 2024 Dec
11];18(3):175–96. Available from:
https://www.nature.com/articles/s41573-018-0006-z
24. Lakshmanan VK,
Jindal S, Packirisamy G, Ojha S, Lian S, Kaushik A, et al. Nanomedicine-based
cancer immunotherapy: recent trends and future perspectives. Cancer Gene Ther.
2021 Sep 1;28(9):911–23.
25. Karahan HE,
Wiraja C, Xu C, Wei J, Wang Y, Wang L, et al. Graphene Materials in
Antimicrobial Nanomedicine: Current Status and Future Perspectives. Adv Healthc
Mater. 2018 Jul 11;7(13).